Home Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission ...
 

Keywords :   


Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission ...

2014-12-24 16:54:20| Biotech - Topix.net

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc. announced today that they have submitted a New Drug Application for Buprenorphine HCl Buccal Film to the U.S. Food and Drug Administration . Buprenorphine HCl Buccal Film is under development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Tags: sciences submission announce pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
More »